Matches in Wikidata for { <http://www.wikidata.org/entity/Q59171530> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q59171530 description "article" @default.
- Q59171530 description "im April 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59171530 description "wetenschappelijk artikel" @default.
- Q59171530 description "наукова стаття, опублікована у квітні 2015" @default.
- Q59171530 description "հոդված" @default.
- Q59171530 name "Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease" @default.
- Q59171530 name "Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease" @default.
- Q59171530 type Item @default.
- Q59171530 label "Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease" @default.
- Q59171530 label "Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease" @default.
- Q59171530 prefLabel "Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease" @default.
- Q59171530 prefLabel "Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease" @default.
- Q59171530 P1433 Q59171530-C89EC7D2-F125-496E-A86A-AAC9C487BC4F @default.
- Q59171530 P1476 Q59171530-819E964E-7BF2-41D4-9B12-6CAAF4C1EE08 @default.
- Q59171530 P2093 Q59171530-0BC49ED4-14D3-41C0-B15F-8FC374796439 @default.
- Q59171530 P2093 Q59171530-5C468855-59C1-49F1-9291-78CB475A65F8 @default.
- Q59171530 P2093 Q59171530-76DF2E74-96EA-4C23-A129-F683C58DDE90 @default.
- Q59171530 P2093 Q59171530-8A10BEF7-EB2C-41F2-8233-73B732921917 @default.
- Q59171530 P2093 Q59171530-C585C46B-E49F-49D5-B5E7-F44F5CA399F5 @default.
- Q59171530 P2093 Q59171530-D072079B-6493-4147-815E-5D194BE0865B @default.
- Q59171530 P2093 Q59171530-DA81B7E6-9219-4218-9D7F-985EB4385A91 @default.
- Q59171530 P2093 Q59171530-E48CB8E5-010D-4AEE-BCC2-7B8A3323D857 @default.
- Q59171530 P2093 Q59171530-FA7182BB-80BE-4C25-B933-A0923953C72D @default.
- Q59171530 P304 Q59171530-1B26D606-5AE2-4CEA-8A00-CF0B25438871 @default.
- Q59171530 P31 Q59171530-38AE9D8D-9A3C-4CE6-9D4B-D20A647D79F6 @default.
- Q59171530 P356 Q59171530-6BF2D4D9-8A1E-4512-8F21-6BC55B080CF2 @default.
- Q59171530 P433 Q59171530-8DF1FBDC-74C7-4245-B53E-7FBBA665B7DC @default.
- Q59171530 P478 Q59171530-7543DEE9-6926-4943-9089-59456A21113B @default.
- Q59171530 P50 Q59171530-54BF86D1-9A88-4C6D-AB7B-5557303DA2B1 @default.
- Q59171530 P50 Q59171530-AC6C6A6C-F0F4-4D53-8D9B-0C781FA121D2 @default.
- Q59171530 P50 Q59171530-B9589608-AD50-48B3-94F2-A610BEF63316 @default.
- Q59171530 P577 Q59171530-4135057A-30AE-4BF7-AE86-8942B982E1E3 @default.
- Q59171530 P698 Q59171530-4BF0864B-AE19-4A44-B476-5582D53C7B1F @default.
- Q59171530 P356 1389557515666150219130156 @default.
- Q59171530 P698 25694076 @default.
- Q59171530 P1433 Q3314982 @default.
- Q59171530 P1476 "Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease" @default.
- Q59171530 P2093 "Jose Marco-Contelles" @default.
- Q59171530 P2093 "José I Borrell" @default.
- Q59171530 P2093 "Manuela G López" @default.
- Q59171530 P2093 "Marta Pérez" @default.
- Q59171530 P2093 "Matilde Yañez" @default.
- Q59171530 P2093 "Mourad Chioua" @default.
- Q59171530 P2093 "Oscar M Bautista-Aguilera" @default.
- Q59171530 P2093 "Raimon Puig de la Bellacasa" @default.
- Q59171530 P2093 "Ramón Cacabelos" @default.
- Q59171530 P304 "648-658" @default.
- Q59171530 P31 Q13442814 @default.
- Q59171530 P356 "10.2174/1389557515666150219130156" @default.
- Q59171530 P433 "8" @default.
- Q59171530 P478 "15" @default.
- Q59171530 P50 Q39676340 @default.
- Q59171530 P50 Q53343131 @default.
- Q59171530 P50 Q53343910 @default.
- Q59171530 P577 "2015-01-01T00:00:00Z" @default.
- Q59171530 P698 "25694076" @default.